Literature DB >> 24091542

"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging.

Rosa Maria Paragliola1, Francesco Torino, Paola Senes, Laura Castellino, Vanda Salutari, Alfredo Pontecorvi, Giovanni Scambia, Salvatore M Corsello.   

Abstract

Hyperandrogenism is a common finding in premenopausal age and is generally caused by polycystic ovarian syndrome or other benign disease. Androgen-secreting tumors represent only 0.2 % of the causes of hyperandrogenism and usually present with severe clinical features, abrupt onset, and very high androgens levels. We describe here three cases of occult ovarian Leydig cell tumors suspected on the basis of severe clinical features of hyperandrogenism rapidly worsening, with elevated serum total testosterone levels, in which bilateral ovariectomy was performed and tumor was confirmed by post-operative histology. In all three cases, imaging was negative for ovarian tumor. Moreover, in one case the confounding concomitant finding of bilateral adrenal masses posed an additional challenge. Our experience highlights that testosterone levels represent the most helpful marker in the diagnosis of androgen-secreting ovarian tumor. In the absence of imaging findings, bilateral ovariectomy should be indicated, if supported by unequivocal clinical and laboratory data.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24091542     DOI: 10.1007/s12020-013-0066-0

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  24 in total

1.  Toward excellence in testosterone testing: a consensus statement.

Authors:  William Rosner; Hubert Vesper
Journal:  J Clin Endocrinol Metab       Date:  2010-10       Impact factor: 5.958

Review 2.  Clinical practice. Hirsutism.

Authors:  Robert L Rosenfield
Journal:  N Engl J Med       Date:  2005-12-15       Impact factor: 91.245

3.  [A rare case of hyperandrogenism: bilateral Leydig cell tumor of the ovary].

Authors:  M Marcelino; Ema Nobre; J Conceição; L Lopes; H Vilar; M França Martins; A Carvalho; S André; A Horta; J Jácome De Castro
Journal:  Acta Med Port       Date:  2010-02-10

4.  Extensive clinical experience: relative prevalence of different androgen excess disorders in 950 women referred because of clinical hyperandrogenism.

Authors:  E Carmina; F Rosato; A Jannì; M Rizzo; R A Longo
Journal:  J Clin Endocrinol Metab       Date:  2005-11-01       Impact factor: 5.958

Review 5.  Clinical syndromes associated with ovarian neoplasms: a comprehensive review.

Authors:  Alampady Krishna Prasad Shanbhogue; Divya Krishna Prasad Shanbhogue; Srinivasa R Prasad; Venkateswar R Surabhi; Najla Fasih; Christine O Menias
Journal:  Radiographics       Date:  2010 Jul-Aug       Impact factor: 5.333

6.  Bilateral virilizing hilus (Leydig) cell tumors of the ovary.

Authors:  S Duun
Journal:  Acta Obstet Gynecol Scand       Date:  1994-01       Impact factor: 3.636

7.  Bilateral Leydig cell tumour of the ovary: a rare cause of virilization in postmenopausal patient.

Authors:  Olga Asín Sanz; Pilar Rubio Martinez; Rosa Troyas Guarch; María José Iriarte Goñi; Juan Luis Zambrano Alcazar
Journal:  Maturitas       Date:  2007-02-07       Impact factor: 4.342

8.  Androgen excess in women: experience with over 1000 consecutive patients.

Authors:  R Azziz; L A Sanchez; E S Knochenhauer; C Moran; J Lazenby; K C Stephens; K Taylor; L R Boots
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

9.  Leydig cell hyperplasia and Leydig cell tumour in postmenopausal women: report of two cases.

Authors:  Maarten Hofland; Stef Cosyns; Philippe De Sutter; Claire Bourgain; Brigitte Velkeniers
Journal:  Gynecol Endocrinol       Date:  2012-07-26       Impact factor: 2.260

Review 10.  Selective venous sampling for androgen-producing ovarian pathology.

Authors:  Eric D Levens; Brian W Whitcomb; John M Csokmay; Lynnette K Nieman
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-21       Impact factor: 3.478

View more
  3 in total

1.  SEVERE HYPERANDROGENISM IN A PREMENOPAUSAL WOMAN WITH AN IMAGING-NEGATIVE LEYDIG CELL TUMOR.

Authors:  Stephanie B Lubchansky; Ruth McManus
Journal:  AACE Clin Case Rep       Date:  2020-06-23

2.  Adrenal Incidentaloma Camouflaging an Ovarian Leydig Cell Tumour: A Look Beneath the Surface.

Authors:  Harsh Durgia; Sadishkumar Kamalanathan; Jayaprakash Sahoo; Murali Subbaiah; Nachiappa G Rajesh; Sagili Vijaya Bhaskar Reddy
Journal:  J Obstet Gynaecol India       Date:  2021-02-18

3.  MENOPAUSAL ANDROGEN EXCESS - ASSOCIATED CARDIO-METABOLIC RISK: CLUES FOR OVARIAN LEYDIG CELL TUMOUR (CASE REPORT AND MINI-REVIEW OF LITERATURE).

Authors:  A A Gheorghisan-Galateanu; D Terzea; A Valea; M Carsote
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Jul-Sep       Impact factor: 0.877

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.